0867 Share Price

Open 13.70 Change Price %
High 13.80 1 Day -0.20 -1.45
Low 13.50 1 Week -0.26 -1.87
Close 13.62 1 Month 0.12 0.89
Volume 1799199 1 Year 3.28 31.72
52 Week High 14.56
52 Week Low 10.38
0867 Important Levels
Resistance 2 13.90
Resistance 1 13.78
Pivot 13.64
Support 1 13.46
Support 2 13.34
HKG HongKong Most Active Stocks
0136 0.13 0.00%
0566 3.91 0.00%
0139 0.27 -3.57%
0582 0.11 -8.33%
0061 0.04 0.00%
0939 6.46 0.62%
3988 3.89 0.26%
0621 0.09 12.50%
0559 0.26 4.00%
1398 5.19 0.58%
More..
HKG HongKong Top Gainers Stocks
8269 0.18 20.00%
0759 0.86 19.44%
0723 0.07 16.67%
0834 3.32 16.49%
0376 4.35 13.87%
8250 0.09 12.50%
0313 0.09 12.50%
0621 0.09 12.50%
0835 0.09 12.50%
0279 0.56 12.00%
More..
HKG HongKong Top Losers Stocks
8037 0.58 -17.14%
8002 4.00 -15.97%
0472 0.78 -11.36%
8080 0.08 -11.11%
0195 0.10 -9.09%
0530 3.27 -8.66%
3303 3.02 -8.48%
0736 0.11 -8.33%
0582 0.11 -8.33%
8063 0.11 -8.33%
More..

China Medical System (HKG: 0867)

0867 Technical Analysis 3
As on 26th May 2017 0867 Share Price closed @ 13.62 and we RECOMMEND Buy for LONG-TERM with Stoploss of 12.78 & Buy for SHORT-TERM with Stoploss of 13.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
0867 Target for May
1st Target up-side 14.25
2nd Target up-side 14.81
3rd Target up-side 15.38
1st Target down-side 12.63
2nd Target down-side 12.07
3rd Target down-side 11.5
0867 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.cms.net.cn
0867 Address
0867
Building A, Tongfang Information Harbour
6th Floor and 8th Floor
Shenzhen, 518057
China
Phone: 86 755 8241 6868
Fax: 86 755 8241 6622
0867 Latest News
Interactive Technical Analysis Chart China Medical System ( 0867 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on China Medical System
0867 Business Profile
China Medical System Holdings Limited produces medicines, as well as markets, promotes, and sells drugs primarily in the People’s Republic of China. The company offers products under the direct and agency networks. Its principal products under the direct network comprise Deanxit for depression and anxiety; Ursofalk for the treatment of cholesterol gallstones, cholestatic liver disease, and bile reflux gastritis; XinHuoSu for the treatment of acute heart failure; Salofalk for the treatment of Ulcerative Colitis and Crohn’s disease; Bioflor for treating diarrhea in adults and children; and Augentropfen Stulln Mono Eye-drops for treating age-related macula degeneration and various forms of ocular asthenopia. The company’s principal products under the agency network consist of ShaDuoLiKa, an injection of anti-infective TCM used in pediatrics, respiratory, and emergency departments; YiNuoShu, an expectorant product used for respiratory diseases; XiDaKang, a protein hydrolysate enteral nutrition agent; and Yin Lian Qing Gan Ke Li, a TCM product to treat various acute and chronic forms of hepatitis, alcoholic liver, fatty liver, and hypertension. It also develops Tyroserleutide, which is under phase III clinical trials and is intended for the treatment of liver cancer. The company was founded in 1995 and is headquartered in Shenzhen, the People’s Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.